Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dushyanth Srinivasan
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
JAMA Neurology
Neurology
Related publications
Antisense Oligonucleotide Therapy for Neurodegenerative Disease
Journal of Clinical Investigation
Medicine
Antisense Oligonucleotide Gene Therapy for Neuromuscular Disorders
University of Ottawa Journal of Medicine
NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen Further Ameliorates Spinal Muscular Atrophy in Mice
American Journal of Human Genetics
Genetics
In Vivo Imaging as a Pharmacodynamic Marker
Clinical Cancer Research
Cancer Research
Oncology
124. AAV-Mediated Antisense Oligonucleotide-Based Therapy for CEP290-Associated LCA
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Antisense Oligonucleotide Hope for Childhood Epilepsies
Nature Reviews Neurology
Molecular Neuroscience
Neurology
Cellular
Antisense Oligonucleotide Treatment for Human Astrocytoma
Genome Biology
A Multi-Targeted Antisense Oligonucleotide-Based Therapy Directed at Phosphodiesterases 4 and 7 for COPD
Figure 1: ATF4 as a Pharmacodynamic Marker in Nontransgenic and hAPP-J20 Mice.
